Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Virginia
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Maine
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Rhode Island
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
D.C.
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Florida
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
New York
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Connecticut
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
New Hampshire
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
20d
| Job Type | Full Time |
Vilarinho Lab - Junior or Assistant Specialist
San Francisco, California
University of California - San Francisco
Application Window Open date: September 28, 2026 Most recent review date: Tuesday, Oct 13, 2026 at 11:59pm (Pacific Time) Applications received after this date will be reviewed by the search committee if the position has not yet been filled...
20d
| Job Type | Full Time |
Division of General Internal Medicine - Research Investigator
San Francisco, California
University of California - San Francisco
Application Window Open date: September 28, 2026 Next review date: Wednesday, Oct 28, 2026 at 11:59pm (Pacific Time) Apply by this date to ensure full consideration by the committee. Final date: Tuesday, Mar 28, 2028 at 11:59pm (Pacific Tim...
20d
| Job Type | Full Time |